The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | The role of AI in surgery for patients with lung cancer
Kelvin Lau, BA, MA, MBBS, PhD, FRCS, Barts Health NHS Trust, London, UK, provides an overview of the role of artificial intelligence (AI) in surgery for patients with lung cancer. AI could be used to predict which patients will benefit from surgery and who may experience complications. In addition, the development of physical AI could allow for autonomous robotic surgery. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
